Corporate Investor

Updated:

Beijing E-Town Biomedical Investment Management

Beijing E-Town Biomedical Investment Management was established in 2010. It functions as the investment arm tied to Beijing E-Town International Investment &...

Beijing E-Town Biomedical Investment Management logo

Beijing E-Town Biomedical Investment Management

Beijing E-Town Biomedical Investment Management was established in 2010. It functions as the investment arm tied to Beijing E-Town International Investment & Development Co., Ltd. The firm targets venture opportunities in healthcare, pharmaceuticals, materials, and consumer discretionary. It maintains a China-only geographic footprint. Confirmed activities include co-hosting the Beijing CGT New Trend Conference in 2024 with Yibo Biotech Group. The firm oversees industrial assets including Beijing E-Town Biomedical Park Phases I and II and Jinghai Industrial Park Phase III. It holds membership in the 48 Group Club and participated in meetings with the group in 2024. The structure links directly to the state-owned E-Town Capital vehicle, which serves as the primary investment platform for the Beijing Economic-Technological Development Area.

General information

Firm type

Corporate Investor

Year founded

2010

AUM

Undisclosed

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Beijing, China

Sector focus

HealthcarePharmaceuticals

Frequently asked questions

Who runs investment decisions at Beijing E-Town Biomedical Investment Management?

No named principals are disclosed in public sources.

How does Beijing E-Town Biomedical Investment Management source proprietary deal flow?

The firm operates through its parent Beijing E-Town International Investment & Development Co., Ltd. and participates in industry conferences such as the 2024 Beijing CGT New Trend Conference.

Is Beijing E-Town Biomedical Investment Management structured as a single family office or does it operate more like a venture firm?

It operates as a corporate investor under a state-owned parent entity focused on venture opportunities.

Does Beijing E-Town Biomedical Investment Management participate in fund commitments or only direct deals?

Public information does not specify fund commitments versus direct investments.

Where does the underlying capital come from?

The firm is tied to Beijing E-Town International Investment & Development Co., Ltd., the primary state-owned investment vehicle for the BDA.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Beijing Corporate Investor profiles